These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38786160)

  • 1. A Difficult Case of Ventriculitis in a 40-Year-Old Woman with Acute Myeloid Leukemia.
    Rubino R; Trizzino M; Pipitò L; Sucato G; Santoro M; Maugeri R; Iacopino DG; Giammanco GM; Siragusa S; Cascio A
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem-Vaborbactam for the Treatment of Post-Neurosurgical Meningitis Caused by KPC Producer Klebsiella Pneumoniae: A Case Report and Review of the Literature.
    Rezzonico LF; Peracchi F; Vecchi M; Bassi G; Merli M; Bana NB; Travi G; Crippa F; Puoti M
    Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam.
    Wenzler E; Scoble PJ
    Infect Dis Ther; 2020 Dec; 9(4):769-784. PubMed ID: 33025557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-Associated Vancomycin-Resistant Enterococcus faecium Ventriculitis and Multidrug-Resistant Acinetobacter baumannii Pneumonia With Subsequent Acinetobacter Ventriculitis: A Case Report.
    Rei KM; Reddy V; Andraos C; Brazdzionis J; Siddiqi J
    Cureus; 2023 Nov; 15(11):e49058. PubMed ID: 38116362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections.
    Bhowmick T; Weinstein MP
    Infect Dis Ther; 2020 Dec; 9(4):757-767. PubMed ID: 33017041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem/vaborbactam activity
    Romanelli F; Stolfa S; Morea A; Ronga L; Prete RD; Chironna M; Santacroce L; Mosca A
    Future Microbiol; 2021 Nov; 16():1261-1266. PubMed ID: 34674551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis.
    Nevrekar S; Cunningham KC; Greathouse KM; Panos NG
    Ann Pharmacother; 2014 Feb; 48(2):274-8. PubMed ID: 24259634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Existing and Emerging Data for Meropenem-Vaborbactam.
    Shoulders BR; Casapao AM; Venugopalan V
    Clin Ther; 2020 Apr; 42(4):692-702. PubMed ID: 32147146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracic aorta graft infection by avibactam-resistant KPC-producing
    Belati A; Novara R; Bavaro DF; Procopio A; Fico C; Diella L; Romanelli F; Stolfa S; Mosca A; Di Gennaro F; Saracino A
    Infez Med; 2022; 30(2):277-284. PubMed ID: 35693053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Post-Neurosurgical Infection due to KPC-Producing Klebsiella pneumoniae Treated with Meropenem-Vaborbactam: A Case Report.
    Choi S; Fedorenko M; Lin-Torre J; Mistry N; Smoke S
    Int J Infect Dis; 2022 Sep; 122():1041-1043. PubMed ID: 35932967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V; Principe L; Andriani L; Aiezza N; Coppi M; Ricci S; Giani T; Luzzaro F; Rossolini GM
    Clin Microbiol Infect; 2023 Apr; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae.
    Sabet M; Tarazi Z; Nolan T; Parkinson J; Rubio-Aparicio D; Lomovskaya O; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular Plus Systemic Antibiotic Therapy for Treating Polymyxin-Resistant
    Wang H; Zhou Q; Huang K; Yang X; Wen L
    Open Forum Infect Dis; 2022 Apr; 9(4):ofac084. PubMed ID: 35355891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid.
    Maranich AM; Rajnik M
    Mil Med; 2008 Sep; 173(9):927-9. PubMed ID: 18816936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meropenem-vaborbactam for adults with complicated urinary tract and other invasive infections.
    Albin OR; Patel TS; Kaye KS
    Expert Rev Anti Infect Ther; 2018 Dec; 16(12):865-876. PubMed ID: 30372359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections.
    Bouza E
    J Antimicrob Chemother; 2021 Nov; 76(Suppl 4):iv38-iv45. PubMed ID: 34849998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.